Real-world outcomes from treating adults with moderate-to-severe atopic dermatitis with dupilumab are similar to what researchers have found in clinical trials, according to this study.
Videos Atopic Dermatitis
In this Medical News Minute, Dr. Lazzara discusses the findings of a recent study that examined the dosage of an experimental drug for the treatment of itchy skin in people with atopic dermatitis.
Dermatologists should not depend on a rescue approach for atopic dermatitis flares, says a recent paper. Instead, they should talk with patients about newer treatment options that could offer long-term disease with minimal adverse events.
In this video, Dr. Lazzara discusses a study that examined operational definitions of atopic dermatitis in the literature, and their potential effect on prevalence and associated risk factors.
Twenty-five percent of adults with atopic dermatitis report the disease started in adulthood. Yet, diagnosing adult-onset atopic dermatitis can challenge even expert clinicians. Here's what you need to know.
Two recent studies—one looking at atopic dermatitis prevalence and disease severity in U.S.
Published in the British Journal of Dermatology, a cross sectional population-based study
Are you training your patients on how to use their self-injectable medications safely and effectively? If not, you may want to start, according to researchers of a recent study, which examined patient behavior surrounding self-injection devices.
In this Medical News Minute, Dr. Bobby Lazzara discusses the specifics regarding injection site reactions.
The differential diagnosis of atopic dermatitis can be challenging. Our expert, Dr. Robert Lazarra, highlights the basic criteria you need to know in this video.